Upregulation of enzymes metabolizing 5-fluorouracil in colorectal cancer

被引:15
|
作者
Matsusaka, Satoshi [1 ]
Yamasaki, Hajime [1 ]
Fukushima, Masakazu [1 ]
Wakabayashi, Ichiro [1 ]
机构
[1] Yamagata Univ, Sch Med, Dept Hyg & Prevent Med, Yamagata 9909585, Japan
关键词
colorectal cancer; 5-fluorouracil; lymph node metastasis; orotate phosphoribosyltransferase; ribonucleotide reductase;
D O I
10.1159/000098249
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The purpose of this study was to compare the activities of various enzymes, participating in the metabolism of 5-fluorouracil, between colorectal cancer and nontumor tissues and to investigate the association of the enzyme activities with clinicopathological backgrounds. Methods: Activities of seven enzymes involved in nucleic acid metabolism - orotate phosphoribosyltransferase (OPRT), ribonucleotide reductase (RNR), thymidylate synthase, dihydropyrimidine dehydrogenase, thymidine phosphorylase, uridine phosphorylase and thymidine kinase (TK) - were measured in tumor and nontumor tissues from 28 patients who were operated on for colorectal cancers. Results: OPRT, thymidylate synthase, RNR, thymidine phosphorylase, uridine phosphorylase and thymidine kinase activities were significantly higher in tumor areas than in nontumor areas. OPRT showed the highest T/N ratio ( the ratio of each enzyme activity in tumor areas to that in nontumor areas). The T/N ratio of RNR activity showed a tendency to be associated with lymph node metastasis and Dukes classification. Conclusion: The results suggest that OPRT is a main enzyme participating in the phosphorylation of 5-fluorouracil and has an important role in tumor growth. The T/N ratio of RNR may be predictive of tumor progression. Copyright (c) 2007 S. Karger AG, Basel
引用
收藏
页码:36 / 41
页数:6
相关论文
共 50 条
  • [31] Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer
    Chau, I
    Webb, A
    Cunningham, D
    Hill, M
    Waters, JS
    Norman, A
    Massey, A
    BRITISH JOURNAL OF CANCER, 2001, 85 (09) : 1258 - 1264
  • [32] Prognostic impact of orotate phosphoribosyl transferase among 5-fluorouracil metabolic enzymes in resectable colorectal cancers treated by oral 5-fluorouracil-based adjuvant chemotherapy
    Ochiai, Takumi
    Nishimura, Kazuhiko
    Noguchi, Hajime
    Kitajima, Masayuki
    Tsukada, Akira
    Watanabe, Emiko
    Nagaoka, Isao
    Futagawa, Shunji
    INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (12) : 3084 - 3088
  • [33] Synergistic antitumor effect of 5-fluorouracil in combination with parthenolide in human colorectal cancer
    Kim, Se-Lim
    Kim, Seong Hun
    Kieu Thi Thu Trang
    Kim, In Hee
    Lee, Seung-Ok
    Lee, Soo Teik
    Kim, Dae Ghon
    Kang, Sang-Beom
    Kim, Sang-Wook
    CANCER LETTERS, 2013, 335 (02) : 479 - 486
  • [34] Gene expression of 5-fluorouracil metabolic enzymes in primary gastric cancer: Correlation with drug sensitivity against 5-fluorouracil
    Kodera, Yasuhiro
    Ito, Seiji
    Fujiwara, Michitaka
    Mochizuki, Yoshinari
    Nakayama, Goro
    Ohashi, Norifumi
    Koike, Masahiko
    Yamamura, Yoshitaka
    Nakao, Akimasa
    CANCER LETTERS, 2007, 252 (02) : 307 - 313
  • [35] Sex-Dependent Adverse Drug Reactions to 5-Fluorouracil in Colorectal Cancer
    Lim, Hyesol
    Kim, Sun Young
    Lee, Eunhye
    Lee, Seungeun
    Oh, Sungryong
    Jung, Joohee
    Kim, Kwi Suk
    Moon, Aree
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2019, 42 (04) : 594 - 600
  • [36] Investigating the role of nucleoside transporters in the resistance of colorectal cancer to 5-fluorouracil therapy
    Phua, Lee Cheng
    Mal, Mainak
    Koh, Poh Koon
    Cheah, Peh Yean
    Chan, Eric Chun Yong
    Ho, Han Kiat
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (03) : 817 - 823
  • [37] Sirolimus, bevacizumab, 5-Fluorouracil and irinotecan for advanced colorectal cancer: A pilot study
    Ghiringhelli, Francois
    Guiu, Boris
    Chauffert, Bruno
    Ladoire, Sylvain
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (34) : 4278 - 4283
  • [38] Sirolimus,bevacizumab,5-Fluorouracil and irinotecan for advanced colorectal cancer:A pilot study
    Francois Ghiringhelli
    Boris Guiu
    Bruno Chauffert
    Sylvain Ladoire
    World Journal of Gastroenterology, 2009, 15 (34) : 4278 - 4283
  • [39] Inhibition of phosphoserine phosphatase enhances the anticancer efficacy of 5-fluorouracil in colorectal cancer
    Li, Xin
    Xun, Zhe
    Yang, Yong
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 477 (04) : 633 - 639
  • [40] Circadian rhythm of 5-fluorouracil population pharmacokinetics in patients with metastatic colorectal cancer
    Bressolle, F
    Joulia, JM
    Pinguet, F
    Ychou, M
    Astre, C
    Duffour, J
    Gomeni, R
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 44 (04) : 295 - 302